Changes in choroidal imaging parameters following adalimumab therapy for refractory noninfectious uveitis.
Ryuto NishishoSentaro KusuharaNoriyuki SotaniKyong Woo KimAtsuko Katsuyama-YoshikawaWataru MatsumiyaKengo AkashiAkio MorinobuMakoto NakamuraPublished in: Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie (2021)
In the assessment of short-term response to ADA treatment in uveitic eyes, using EDI-OCT, the SFCT appears to be more effective as a choroidal imaging biomarker than the CSI, especially in VKHD eyes.